Iron Status and Supplementation during Tuberculosis.

Microorganisms

Centre of Excellence for Nutrition, North-West University, Potchefstroom 2531, South Africa.

Published: March 2023

Tuberculosis (TB) is characterised by chronic non-resolving inflammation. The effects of the host immune and inflammatory response to reduce iron acquisition by the bacteria, together with other contributing factors, predispose TB patients to anaemia of infection and iron deficiency anaemia (IDA). The presence of anaemia in TB patients has been linked to poor clinical outcomes. However, due to the reliance of the bacteria on iron, the management of anaemia in TB is complicated, and anaemia of infection is likely to resolve with correct TB drug treatment. On the other hand, IDA may require iron supplementation. This review aims to describe iron metabolism in TB and how this contributes to the development of iron deficiency and anaemia. Additionally, we summarise the evidence on the association between iron status and clinical outcomes as well as the available preclinical and clinical trials on iron supplementation in TB.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055784PMC
http://dx.doi.org/10.3390/microorganisms11030785DOI Listing

Publication Analysis

Top Keywords

iron
9
iron status
8
anaemia infection
8
iron deficiency
8
deficiency anaemia
8
clinical outcomes
8
iron supplementation
8
anaemia
6
status supplementation
4
supplementation tuberculosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!